TREATMENT OF PRECOCIOUS PUBERTY WITH LHRH ANALOGUE IN COMBINATION WITH CYPROTERONE ACETATE—FURTHER EXPERIENCE

R. KAULI, A. PERTZELAN, Z. BEN‐ZEEV, R. PRAGER LEWIN, H. KAUFMAN, A. M COMARU SCHALLY, Andrew V Schally, Z. LARON

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Six girls and one boy with precocious puberty were treated with a superactive LHRH analogue (D‐TRP6‐LHRH) for periods ranging from 1 year to 2 years and 3 months. In the first phase of the treatment it was administered in combination with cyproterone acetate (CyA) to counteract an early stimulatory effect until inhibition of gonadotrophin secretion was achieved. The gonadotrophin‐dependent signs i.e. gonadarche, showed sustained arrest and even regression. Gonadal sex steroids decreased but the adrenal androgens were unaffected. In four patients who showed progression of the angrogen‐dependent signs (adrenarche), despite suppression of gonadotrophins, increasing the dosage of the LHRH analogue was ineffective and combined therapy with CyA was reinstituted in three of them because of accelerated growth and bone maturation. It is concluded that at present the treatment of choice for precocious puberty is the daily administration of a superactive LHRH analogue such as D‐TRP6‐LHRH, together with CyA in the initial stage, and at a later state if adrenarche progresses too rapidly.

Original languageEnglish (US)
Pages (from-to)377-387
Number of pages11
JournalClinical Endocrinology
Volume20
Issue number4
DOIs
StatePublished - 1984
Externally publishedYes

Fingerprint

Cyproterone
Cyproterone Acetate
Precocious Puberty
Adrenarche
Gonadotropin-Releasing Hormone
Gonadotropins
Bone Development
Androgens
Therapeutics
Steroids

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Medicine(all)

Cite this

KAULI, R., PERTZELAN, A., BEN‐ZEEV, Z., LEWIN, R. PRAGER., KAUFMAN, H., SCHALLY, A. M. COMARU., ... LARON, Z. (1984). TREATMENT OF PRECOCIOUS PUBERTY WITH LHRH ANALOGUE IN COMBINATION WITH CYPROTERONE ACETATE—FURTHER EXPERIENCE. Clinical Endocrinology, 20(4), 377-387. https://doi.org/10.1111/j.1365-2265.1984.tb03433.x

TREATMENT OF PRECOCIOUS PUBERTY WITH LHRH ANALOGUE IN COMBINATION WITH CYPROTERONE ACETATE—FURTHER EXPERIENCE. / KAULI, R.; PERTZELAN, A.; BEN‐ZEEV, Z.; LEWIN, R. PRAGER; KAUFMAN, H.; SCHALLY, A. M COMARU; Schally, Andrew V; LARON, Z.

In: Clinical Endocrinology, Vol. 20, No. 4, 1984, p. 377-387.

Research output: Contribution to journalArticle

KAULI, R, PERTZELAN, A, BEN‐ZEEV, Z, LEWIN, RPRAGER, KAUFMAN, H, SCHALLY, AMCOMARU, Schally, AV & LARON, Z 1984, 'TREATMENT OF PRECOCIOUS PUBERTY WITH LHRH ANALOGUE IN COMBINATION WITH CYPROTERONE ACETATE—FURTHER EXPERIENCE', Clinical Endocrinology, vol. 20, no. 4, pp. 377-387. https://doi.org/10.1111/j.1365-2265.1984.tb03433.x
KAULI, R. ; PERTZELAN, A. ; BEN‐ZEEV, Z. ; LEWIN, R. PRAGER ; KAUFMAN, H. ; SCHALLY, A. M COMARU ; Schally, Andrew V ; LARON, Z. / TREATMENT OF PRECOCIOUS PUBERTY WITH LHRH ANALOGUE IN COMBINATION WITH CYPROTERONE ACETATE—FURTHER EXPERIENCE. In: Clinical Endocrinology. 1984 ; Vol. 20, No. 4. pp. 377-387.
@article{aadf107c1fda40799c3e7aa5b6147ef8,
title = "TREATMENT OF PRECOCIOUS PUBERTY WITH LHRH ANALOGUE IN COMBINATION WITH CYPROTERONE ACETATE—FURTHER EXPERIENCE",
abstract = "Six girls and one boy with precocious puberty were treated with a superactive LHRH analogue (D‐TRP6‐LHRH) for periods ranging from 1 year to 2 years and 3 months. In the first phase of the treatment it was administered in combination with cyproterone acetate (CyA) to counteract an early stimulatory effect until inhibition of gonadotrophin secretion was achieved. The gonadotrophin‐dependent signs i.e. gonadarche, showed sustained arrest and even regression. Gonadal sex steroids decreased but the adrenal androgens were unaffected. In four patients who showed progression of the angrogen‐dependent signs (adrenarche), despite suppression of gonadotrophins, increasing the dosage of the LHRH analogue was ineffective and combined therapy with CyA was reinstituted in three of them because of accelerated growth and bone maturation. It is concluded that at present the treatment of choice for precocious puberty is the daily administration of a superactive LHRH analogue such as D‐TRP6‐LHRH, together with CyA in the initial stage, and at a later state if adrenarche progresses too rapidly.",
author = "R. KAULI and A. PERTZELAN and Z. BEN‐ZEEV and LEWIN, {R. PRAGER} and H. KAUFMAN and SCHALLY, {A. M COMARU} and Schally, {Andrew V} and Z. LARON",
year = "1984",
doi = "10.1111/j.1365-2265.1984.tb03433.x",
language = "English (US)",
volume = "20",
pages = "377--387",
journal = "Clinical Endocrinology",
issn = "0300-0664",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - TREATMENT OF PRECOCIOUS PUBERTY WITH LHRH ANALOGUE IN COMBINATION WITH CYPROTERONE ACETATE—FURTHER EXPERIENCE

AU - KAULI, R.

AU - PERTZELAN, A.

AU - BEN‐ZEEV, Z.

AU - LEWIN, R. PRAGER

AU - KAUFMAN, H.

AU - SCHALLY, A. M COMARU

AU - Schally, Andrew V

AU - LARON, Z.

PY - 1984

Y1 - 1984

N2 - Six girls and one boy with precocious puberty were treated with a superactive LHRH analogue (D‐TRP6‐LHRH) for periods ranging from 1 year to 2 years and 3 months. In the first phase of the treatment it was administered in combination with cyproterone acetate (CyA) to counteract an early stimulatory effect until inhibition of gonadotrophin secretion was achieved. The gonadotrophin‐dependent signs i.e. gonadarche, showed sustained arrest and even regression. Gonadal sex steroids decreased but the adrenal androgens were unaffected. In four patients who showed progression of the angrogen‐dependent signs (adrenarche), despite suppression of gonadotrophins, increasing the dosage of the LHRH analogue was ineffective and combined therapy with CyA was reinstituted in three of them because of accelerated growth and bone maturation. It is concluded that at present the treatment of choice for precocious puberty is the daily administration of a superactive LHRH analogue such as D‐TRP6‐LHRH, together with CyA in the initial stage, and at a later state if adrenarche progresses too rapidly.

AB - Six girls and one boy with precocious puberty were treated with a superactive LHRH analogue (D‐TRP6‐LHRH) for periods ranging from 1 year to 2 years and 3 months. In the first phase of the treatment it was administered in combination with cyproterone acetate (CyA) to counteract an early stimulatory effect until inhibition of gonadotrophin secretion was achieved. The gonadotrophin‐dependent signs i.e. gonadarche, showed sustained arrest and even regression. Gonadal sex steroids decreased but the adrenal androgens were unaffected. In four patients who showed progression of the angrogen‐dependent signs (adrenarche), despite suppression of gonadotrophins, increasing the dosage of the LHRH analogue was ineffective and combined therapy with CyA was reinstituted in three of them because of accelerated growth and bone maturation. It is concluded that at present the treatment of choice for precocious puberty is the daily administration of a superactive LHRH analogue such as D‐TRP6‐LHRH, together with CyA in the initial stage, and at a later state if adrenarche progresses too rapidly.

UR - http://www.scopus.com/inward/record.url?scp=0021349023&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021349023&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2265.1984.tb03433.x

DO - 10.1111/j.1365-2265.1984.tb03433.x

M3 - Article

C2 - 6232020

AN - SCOPUS:0021349023

VL - 20

SP - 377

EP - 387

JO - Clinical Endocrinology

JF - Clinical Endocrinology

SN - 0300-0664

IS - 4

ER -